Deep Dive Into Bristol-Myers Squibb Stock: Analyst Perspectives (9 ...

5 days ago · Ratings for Bristol-Myers Squibb BMY were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table …

CouponFollow Extension

9%
OFF

What Are Wall Street Analysts' Target Price For Bristol-Myers …

3 weeks from now

2 days ago · Bristol-Myers Squibb’s stock prices soared 5.9% after the release of its impressive Q3 results on Oct. 31. Driven by the increase in sales of its Growth Portfolio and Eliquis, …

nasdaq.com

$65
OFF

BMY Stock Price | Bristol Myers Squibb Co. Stock Quote (U.S.: …

3 weeks from now

2 days ago · Deep Dive Into Bristol-Myers Squibb Stock: Analyst Perspectives (9 Ratings) Jan. 28, 2025 at 8:01 a.m. ET on Benzinga.com Bristol Myers price target raised to $65 from $60 at …

marketwatch.com

$46
OFF

What Analysts Are Saying About Bristol-Myers Squibb Stock

3 weeks from now

Sep 16, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Bristol-Myers Squibb, presenting an average target of $46.0, a high estimate of $53.00, and a low …

nasdaq.com

17%
OFF

5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade)

3 weeks from now

Nov 25, 2024 · Financial Summary, Q3 2024 (Source: Bristol-Myers Squibb) The surprise on the non-GAAP EPS was even bigger. The actual figure came in ~17% higher than my estimate of …

seekingalpha.com

58%
OFF

Bristol Myers Squibb (BMY) Stock Slides As Market Rises: Facts To …

3 weeks from now

Jan 9, 2025 · Bristol Myers Squibb (BMY Quick Quote BMY - Free Report) ended the recent trading session at $56.81, demonstrating a -0.58% swing from the preceding day's closing …

zacks.com

$120
OFF

Bristol-Myers Squibb's SWOT Analysis: Stock Faces Challenges Amid ...

3 weeks from now

3 days ago · Bristol-Myers Squibb (NYSE: BMY), a global biopharmaceutical company with a market capitalization of nearly $120 billion, finds itself at a critical juncture as it navigates a …

investing.com

$59.90
OFF

BMY Stock Price - Bristol Myers Squibb Co Stock Candlestick Chart

3 weeks from now

Bristol Myers Squibb Co stock is traded at $59.90, ... Deep Dive Into Bristol-Myers Squibb Stock: Analyst Perspectives (9 Ratings) ... Bristol-Myers Squibb Options Trading: A Deep Dive into …

stockscan.io

FAQs about Deep Dive Into Bristol-Myers Squibb Stock: Analyst Perspectives (9 ... Coupon?

Is Bristol-Myers Squibb a good stock to buy?

Analysts like Bristol-Myers Squibb less than other "medical" companies. The consensus rating for Bristol-Myers Squibb is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BMY compares to other companies. ...

Is Bristol-Myers Squibb Co a profitable company?

Bristol-Myers Squibb Co's profitability score is 55/100. The higher the profitability score, the more profitable the company is. Bristol-Myers Squibb Co's solvency score is 44/100. The higher the solvency score, the more solvent the company is. Wall Street analysts forecast BMY stock price to rise over the next 12 months. ...

Is Bristol-Myers Squibb Co (BMY) overvalued or undervalued?

Compared to the current market price of 50.885 USD, Bristol-Myers Squibb Co is Undervalued by 30%. Bristol-Myers Squibb Co (NYSE:BMY) Intrinsic Valuation. Check if BMY is overvalued or undervalued under the bear, base, and bull scenarios of the company's future. ...

Is Bristol-Myers Squibb a risky company?

In a competitive pharmaceutical market, Bristol-Myers Squibb faces risks from patent expirations and the introduction of generic alternatives. Market analysts forecast a lower EPS of 0.93 for the current year, which may signal slower growth expectations moving forward. What is Bristol-Myers Squibb's forecast for 2025? ...

What is Bristol-Myers Squibb (BMY)?

Bristol-Myers Squibb (NYSE: BMY) is a pharma company that "offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases," according to its SA profile, and its next earnings result is due in about a week on Feb. 6th. ...

Why did Bristol-Myers Squibb increase its dividend?

Bristol-Myers Squibb recently increased its quarterly dividend to $0.62, reflecting a commitment to returning value to shareholders and a healthy dividend yield of 4.37%. Revenue for the last quarter was $11.89 billion, surpassing analyst expectations, which suggests strong market demand for its products. ...